Monoamine oxidase inhibitors were linked to the highest risk for cardiovascular Standardized MedDRA Queries. Dopamine reuptake inhibition and binding inhibition are linked to antidepressant-related ...

Depression is one of the most widespread mental health disorders worldwide, affecting approximately 4% of the global ...

LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...

Please provide your email address to receive an email when new articles are posted on . Viloxazine is a noradrenergic/norepinephrine reuptake inhibitor, and trazodone ...